Xiao and coworkers [48] found that DNA-dependent protein kinase (DNA-PK) inhibitor could block IFN secretion and antiviral response, which made tumor cells sensitive to OVs for promoting antitumor oncolysis effect. Here, PRKDC is linked to neoplasm.